Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
7.32M
-
Shares change
-
-5.02M
-
Total reported value, excl. options
-
$6.77M
-
Value change
-
-$6.05M
-
Number of buys
-
17
-
Number of sells
-
-18
-
Price
-
$0.93
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q3 2021
49 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2021.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.32M shares
of 75.5M outstanding shares and own 9.7% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.96M shares), Maven Securities LTD (1.01M shares), BOXER CAPITAL, LLC (920K shares), BlackRock Inc. (713K shares), MORGAN STANLEY (578K shares), RENAISSANCE TECHNOLOGIES LLC (447K shares), GEODE CAPITAL MANAGEMENT, LLC (442K shares), ACT Capital, L.L.C. (218K shares), STATE STREET CORP (150K shares), and FRANKLIN RESOURCES INC (142K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.